Scientists investigate skin Bacteria's role in eczema Flare-Ups
NCT ID NCT06924333
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how bacteria living on the skin influence inflammation and skin barrier damage in people with eczema or other skin diseases. Researchers will collect skin samples and measure things like moisture loss, eczema severity, and quality of life in 100 participants. The goal is to better understand the interaction between skin bacteria and the body's defenses, which could lead to new ways to prevent or treat these conditions.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could point toward new prevention or treatment strategies for eczema and other skin diseases by targeting the skin's bacteria.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any therapy, and findings may not lead to immediate clinical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2025
- Expected to finish
-
Nov 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patints with skin diseases, atopic eczema and eczema. Healthy volonteers.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Skin diseas, atopic eczema, eczema \- Exclusion Criteria: * Inabillity to give informed concent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Eczema are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Skane University Hospital
Lund, Skåne County, 22185, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can monthly selfies and symptom logs reveal how chronic skin diseases flare and settle?
- Can a meditation app soothe teen eczema?
- Can a CBD cream soothe Eczema's relentless itch?
- Can a new pill tame psoriasis? early safety trial begins
- Can a new drug safely control eczema over the long haul?
- New biologic drug aims to clear stubborn eczema in just 24 weeks